Treating patients with COPD: When should we use ICS?

This episode of the Medical Insider COPD podcast starts with Dr Richard Russell and Dr Marc Miravitlles as they discuss the role of inhaled corticosteroids (ICS) in COPD treatment. Listen as they describe which subgroups of patients with COPD are most likely to benefit from ICS and what clinical studies into dual bronchodilation vs. ICS reveal.^1–3 Dr Russell will follow this by discussing key takeaways from a new publication on the prevalence of pulmonary embolism in patients hospitalised with COPD,⁴ and by talking to us about a social media hot topic – singing and COPD. Keep an eye out for future episodes of the Medical Insider COPD podcast!

¹Global Initiative for Chronic Obstructive Lung Disease. Updated 2022. Available at: here. Last accessed: November 2021;
²Brusselle G, et al. Int J Chron Obstruct Pulmon Dis 2015;10:2207–2217;
³Stolz D & Miravitlles M. Eur Respir J 2020;55:2000881;
⁴Couturaud F, et al. JAMA 2021;325:59–68

Disclosures
Dr Marc Miravitlles
Dr Marc Miravitlles has received speaker fees from AstraZeneca, Bial, Boehringer Ingelheim, Chiesi, Cipla, CSL Behring, Grifols, Menarini, Novartis, Rovi, Sandoz and Zambon. He reports consulting fees from AstraZeneca, Atriva Therapeutics, Bial, Boehringer Ingelheim, Chiesi, CSL Behring, Ferrer, Gebro Pharma, GlaxoSmithKline, Grifols, Inhibrx, Laboratorios Esteve, Mereo Biopharma, Novartis, ONO Pharma, Palobiofarma, pH Pharma, Sanofi, SL Spin Therapeutics, Takeda, and Verona Pharma, and research grants from Grifols. 

Bios:

Dr Marc Miravitlles Dr Marc Miravitlles is a Senior Researcher and Consultant at Vall d’Hebron University Hospital, Barcelona, Spain. He was Chair of the Respiratory Infections Group of the European Respiratory Society (ERS) and Guidelines Director of the ERS. He has acted as a consultant for the development of international guidelines on COPD, including the American Thoracic Society and ERS guidelines on exacerbations of COPD. He is also a consultant of the Spanish Ministry of Health for the development of the National Strategy Against COPD and the coordinator of the Spanish National Guidelines for COPD.

This series of podcasts are intended for healthcare professionals only.